MED12 exon 2 mutations in uterine leiomyoma’s in women patients of Tehran Province of Iran


  • Ali Reza Ahmadi BioMedical Sciences Department, Alzahra University, Tehran, Iran
  • H. Porrahim BioMedical Sciences Department, Alzahra University, Tehran, Iran
  • H. Moghadasi BioMedical Sciences Department, Alzahra University, Tehran, Iran
  • N. Najafi BioMedical Sciences Department, Alzahra University, Tehran, Iran
  • A. Rakhshan Department of Pathology, Shohadaye Tajrish Hospital, Tehran, Iran


Uterine leiomyoma’s, Fibroid, Tumor, MED12 exon 2, Mutation


Al-Hendy, A., Salama, S.A., 2006. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J. Soci. Gynecol. Invest., 13, 136-44.

Canevari, R.A., Pontes, A., Rosa, F.E., Rainho, C.A., Rogatto, S.R., 2005. Independent clonal origin of multiple uterine leiomyomas that was determined by X chromosome inactivation and microsatellite analysis. Am. J. Obstet. Gynecol., 193, 1395 – 1403.

Conaway, R.C., Conaway, J.W., 2011. Function and regulation of the mediator complex. Curr. Opin. Genet. Dev. 21, 225–230.

Cramer, S.F., Patel, A., 1990. The frequency of uterine leiomyomas. Am. J. Clin. Pathol., 94, 435–438.

Di, X., Yu, L., Moore, A.B., Castro, L., Zheng, X., Hermon, T., Dixon, D., 2008. A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells. Hum. Reprod., 23, 1873–1883.

Fauconnier, A., Chapron, C., Babaki-Fard, K., Dubuisson, J.B., 2000. Recurrence of leiomyomata after myomectomy. Hum. Reprod. Update., 6, 595–602.

Flynn, M., Jamison, M., Datta, S., Myers, E., 2006. Health care resource use for uterine fibroid tumors in the United States. Am. J. Obstet. Gynecol., 195, 955-64.

Guarnaccia, M.M., Rein, M.S., 2001. Traditional surgical approaches to uterinefibroids: abdominal myomectomy and hysterectomy. Clin. Obstet. Gynecol., 44, 385–400.

Hennig, Y., Wanschura, S., Deichert, U., Bartnitzke, S., Bullerdiek, J., 1996. Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps. Mol. Hum. Reprod., 2, 277-83.

Kjerulff, K.H., Langenberg, P., Seidman, J.D., Stolley, P.D., Guzinski, G.M., 1996. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J. Reprod. Med., 41, 483-90.

Lethaby, A., Vollenhoven, B., 2005. Fibroids (uterine myomatosis, leiomyomas). Am. Fam. Physician., 71, 1753–1756.

M€akinen, N., Mehine, M., Tolvanen, J., 2011. MED12, the mediator complex subunit 12 gene,is mutated at high frequency in uterine leiomyomas. Sci., 334, 252–5.

Mäkinen, N., Mehine, M., Tolvanen, J., 2011. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 334, 252–55.

Markowski, D.N., Bartnitzke, S., Loning, T., Drieschner, N., Helmke, B.M., Bullerdiek, J., 2012. MED12 mutations in uterine fibroids -- their relationship to cytogenetic subgroups. Int. J. Cancer., 131, 1528-1536.

Marshall, L.M., Spiegelman, D., Barbieri, R.L., Goldman, M.B., Manson, J.E., Colditz, G.A., Willett, W.C., Hunter, D.J., 1997. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet. Gynecol., 90, 967-73.

Nilbert, M., Heim, S., 1990. Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer. 2, 3–13.

Parker, W.H., 2007. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil. Steril., 87, 725-36.

Perot, G., Croce, S., Ribeiro, A., 2012. MED12 alterations in both human benign and malignant uterine soft tissue tumors. PLoS One. 7, e40015-e40015.

Rein, M.S., Friedman, A.J., Barbieri, R.L., Pavelka, K., Fletcher, J.A., 1991. Cytogenetic abnormalities in uterine leiomyomata. Obstet. Gynecol., 77, 923–926.

Risheg, H., Graham, J.M.J.R., Clark, R.D., Rogers, R.C., Opitz, J.M., Moeschler, J.B., Peiffer, A.P., May, M., Joseph, S.M., Jones, J.R., Stevenson, R.E., Schwartz, C.E., Friez, M.J., 2007. A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome. Nat. Genet., 39, 451-453.

Schwartz, C.E., Tarpey, P.S., Lubs, H.A., Verloes, A., May, M.M., Risheg, H., Friez, M.J., Futreal, P.A., Edkins, S., Teague, J., Briault, S., Skinner, C., Bauer-Carlin, A., Simensen, R.J., Joseph, S.M., Jones, J.R., Gecz, J., Stratton, M.R., Raymond, F.L., Stevenson, R.E., 2007. The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene. J. Med. Genet., 44, 472-477.

Taatjes, D.J., 2010. The human mediator complex: a versatile, genome-wide regulator of transcription. Trend. Biochem. Sci., 35, 315–322.

Templeman, C., Marshall, S.F., Clarke, C.A., Henderson, K.D., Largent, J., Neuhausen, S., Reynolds, P., Ursin, G., Bernstein, L., 2009. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertility and Sterility. 92, 1436-46.

Velagaleti, G.V., Tonk, V.S., Hakim, N.M., 2010. Fusion of HMGA2 to COG5 in uterine leiomyoma. Cancer Genet Cytogenet. 202, 11-6.



How to Cite

Ahmadi, A. R. ., H. Porrahim, H. Moghadasi, N. Najafi, & A. Rakhshan. (2016). MED12 exon 2 mutations in uterine leiomyoma’s in women patients of Tehran Province of Iran. Scientific Journal of Biological Sciences, 5(1), 103-108. Retrieved from



Original Article